about
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyNegative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathwayTranscript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.Minimal changes in the systemic immune response after nephrectomy of localized renal masses.Telomere length in relation to immunological parameters in patients with renal cell carcinomaHuman renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.Immune signature of tumor infiltrating immune cells in renal cancer.Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapyExploiting natural anti-tumor immunity for metastatic renal cell carcinoma.Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinomaLymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directionsImmunotherapy for renal cell cancer in the era of targeted therapy.Prowling wolves in sheep's clothing: the search for tumor stem cells.Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches.Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c-Jun activation.Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor.
P2860
Q26783291-240D8FFF-803F-49DA-BDC5-273441A56089Q33914138-52EF806C-D2E9-4084-AAC3-C8FF1EC718F6Q34003558-4AF4E90A-F43D-462C-866A-1E909FC6DCF0Q34014728-C76E1BB0-7B4B-4703-B897-51212AC10D6CQ34577167-36BECA4F-235E-48D7-B341-26936EFCCEFAQ35070193-E4742E27-1344-4DD1-A14A-53359A6689A8Q35201895-8EAFC884-4439-4C28-B2AB-F38CD2486221Q35721553-C9B79703-26A6-426F-BE32-AB94509FA133Q35887319-B5FC61B9-9CA3-47CD-915C-FE6ED7F303FAQ36442539-C2B1250C-7A77-4F8E-83ED-BCE58F760D0FQ36532950-9ADDBBCC-99AD-44FD-B480-53CE377F54F5Q36954166-89E2DF13-8FD9-4C8A-ADF3-E7611F8BF5A3Q37183451-1A4C3141-F4CE-4465-BC92-49546FBF7D70Q37216610-5CAE6765-1770-4847-A001-9A750D038706Q37229927-144C5352-304A-49A7-BBC0-F0093BB46A54Q37622164-7B5E0C0A-DDD5-4DD7-9553-EE9A508FB00AQ38099023-55083EA7-010A-438C-B5F2-7A75CD4C9A74Q39478425-E18FD202-C810-45EF-B4D6-B8585B6145A0Q39633315-883B96FC-1CC5-41BD-8013-6DE9095A7DC6Q44320068-6B5BE482-045A-4C50-BBBF-DEE0FBACF1D6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immune suppression in renal cell carcinoma.
@en
type
label
Immune suppression in renal cell carcinoma.
@en
prefLabel
Immune suppression in renal cell carcinoma.
@en
P2093
P1476
Immune suppression in renal cell carcinoma.
@en
P2093
Bernhard Frankenberger
Dolores J Schendel
Elfriede Noessner
P304
P356
10.1016/J.SEMCANCER.2007.06.004
P577
2007-06-23T00:00:00Z